E Vallée

872 total citations
31 papers, 642 citations indexed

About

E Vallée is a scholar working on Epidemiology, Pharmacology and Molecular Medicine. According to data from OpenAlex, E Vallée has authored 31 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 16 papers in Pharmacology and 10 papers in Molecular Medicine. Recurrent topics in E Vallée's work include Pneumonia and Respiratory Infections (17 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers) and Antibiotic Resistance in Bacteria (10 papers). E Vallée is often cited by papers focused on Pneumonia and Respiratory Infections (17 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers) and Antibiotic Resistance in Bacteria (10 papers). E Vallée collaborates with scholars based in France, United States and Tunisia. E Vallée's co-authors include E. Azoulay-Dupuis, J J Pocidalo, E Bergogne-Bérézin, Pierre Moine, J J Pocidalo, J Bauchet, A. Philippon, Jean Pierre Bedos, C Carbon and Martine Muffat‐Joly and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

E Vallée

28 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Vallée France 16 419 307 266 157 80 31 642
Martin J. Gill United Kingdom 8 323 0.8× 245 0.8× 314 1.2× 126 0.8× 80 1.0× 16 656
A. Tarasi Italy 12 261 0.6× 162 0.5× 291 1.1× 165 1.1× 117 1.5× 31 607
A. M. Clarke Canada 14 205 0.5× 166 0.5× 138 0.5× 166 1.1× 47 0.6× 30 566
A Kazmierczak France 13 206 0.5× 179 0.6× 230 0.9× 134 0.9× 60 0.8× 47 477
J. P. Maskell United Kingdom 17 263 0.6× 150 0.5× 174 0.7× 195 1.2× 63 0.8× 35 705
Joy Lipka United States 8 287 0.7× 269 0.9× 340 1.3× 195 1.2× 20 0.3× 9 658
C E Fasching United States 14 195 0.5× 225 0.7× 181 0.7× 125 0.8× 71 0.9× 22 575
Kensuke Nagai United States 13 582 1.4× 190 0.6× 235 0.9× 232 1.5× 228 2.9× 24 768
Ryoji Yoshida Japan 10 356 0.8× 129 0.4× 178 0.7× 131 0.8× 224 2.8× 18 652
P. Hohl Switzerland 11 231 0.6× 260 0.8× 232 0.9× 271 1.7× 59 0.7× 26 578

Countries citing papers authored by E Vallée

Since Specialization
Citations

This map shows the geographic impact of E Vallée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Vallée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Vallée more than expected).

Fields of papers citing papers by E Vallée

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Vallée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Vallée. The network helps show where E Vallée may publish in the future.

Co-authorship network of co-authors of E Vallée

This figure shows the co-authorship network connecting the top 25 collaborators of E Vallée. A scholar is included among the top collaborators of E Vallée based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Vallée. E Vallée is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Childress, April L., et al.. (2025). The Current Landscape of Molecular Pathology for the Diagnosis and Treatment of Ependymoma. SHILAP Revista de lepidopterología. 6(3). 23–23.
2.
3.
Darras-Joly, C, Jean Pierre Bedos, Pierre Moine, et al.. (1996). Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrobial Agents and Chemotherapy. 40(9). 2147–2151. 35 indexed citations
4.
Veber, Benoît, B. Dureuil, E Vallée, et al.. (1995). Influence De La Ventilation Artificielle Sur La Gravite Et La Mortalite D'Une Pneumonie Experimentale A Haemophilus Influenzae Type B. Annales Françaises d Anesthésie et de Réanimation. 14. R106–R106. 1 indexed citations
5.
Vallée, E, et al.. (1995). Pneumonies à S. pneumoniae de sensibilité diminuée à la pénicilline : données épidémiologiques, facteurs de risque et impact thérapeutique. Médecine et Maladies Infectieuses. 25(5). 740–747. 10 indexed citations
6.
Lariven, Sylvie, Élisabeth Bouvet, & E Vallée. (1995). Infection à Mycobacterium bovis souche BCG chez un adulte infecté par le VIH. Médecine et Maladies Infectieuses. 25(12). 1220–1222.
7.
Maslo, Caroline, et al.. (1995). [Mycobacterium gordonae infections in human immunodeficiency virus infection].. PubMed. 24(25). 1157–60. 3 indexed citations
8.
Carpentier, E, M. Dailloux, E Vallée, et al.. (1995). Diagnosis of tuberculosis by Amplicor Mycobacterium tuberculosis test: a multicenter study. Journal of Clinical Microbiology. 33(12). 3106–3110. 79 indexed citations
9.
Longuet, P., et al.. (1993). [Vancomycin in meningitis caused by penicillin G resistant Streptococcus pneumoniae].. PubMed. 22(36). 1818–9. 8 indexed citations
10.
Cochereau-Massin, I, J Bauchet, Azzam Saleh‐Mghir, et al.. (1993). Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis. Antimicrobial Agents and Chemotherapy. 37(4). 633–636. 21 indexed citations
11.
Veber, Benoît, E Vallée, J.M. Desmonts, J J Pocidalo, & E. Azoulay-Dupuis. (1993). Correlation between macrolide lung pharmacokinetics and therapeutic efficacy in a mouse model of pneumococcal pneumonia. Journal of Antimicrobial Chemotherapy. 32(3). 473–482. 24 indexed citations
12.
Vallée, E, E. Azoulay-Dupuis, J J Pocidalo, & E Bergogne-Bérézin. (1992). Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection. Antimicrobial Agents and Chemotherapy. 36(7). 1412–1417. 27 indexed citations
13.
14.
Vallée, E, E. Azoulay-Dupuis, J Bauchet, & J J Pocidalo. (1992). Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.. Journal of Pharmacology and Experimental Therapeutics. 262(3). 1203–1208. 6 indexed citations
15.
Azoulay-Dupuis, E., J. P. Bédos, E Vallée, & J J Pocidalo. (1991). Comparative activity of fluorinated quinolones in acute and subacute Streptococcus pneumoniae pneumonia models: efficacy of temafloxacin. Journal of Antimicrobial Chemotherapy. 28(suppl C). 45–53. 21 indexed citations
16.
Vallée, E, et al.. (1991). Pharmacokinetics of four fluoroquinolones in an animal model of infected lung. Journal of Antimicrobial Chemotherapy. 28(suppl C). 39–44. 16 indexed citations
17.
Vallée, E, E. Azoulay-Dupuis, R. N. Swanson, E Bergogne-Bérézin, & J J Pocidalo. (1991). Individual and combined activities of clarithromycin and its 14-hydroxy metabolite in a murine model of Haemophilus influenzae infection. Journal of Antimicrobial Chemotherapy. 27(suppl A). 31–41. 19 indexed citations
18.
Azoulay-Dupuis, E., et al.. (1991). Antipneumococcal Activity of Ciprofloxacin, Ofloxacin, and Temafloxacin in an Experimental Mouse Pneumonia Model at Various Stages of the Disease. The Journal of Infectious Diseases. 163(2). 319–324. 50 indexed citations
19.
Vallée, E, Marie‐Laure Joly‐Guillou, & E Bergogne-Bérézin. (1990). [Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus].. PubMed. 19(13). 588–91. 7 indexed citations
20.
Vallée, E, et al.. (1988). Distribution of β-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus. Journal of Antimicrobial Chemotherapy. 22(5). 597–604. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin J. Gill Breakdown of academic impact, for papers by A. Tarasi Breakdown of academic impact, for papers by A. M. Clarke Breakdown of academic impact, for papers by A Kazmierczak Breakdown of academic impact, for papers by J. P. Maskell Breakdown of academic impact, for papers by Joy Lipka Breakdown of academic impact, for papers by C E Fasching Breakdown of academic impact, for papers by Kensuke Nagai Breakdown of academic impact, for papers by Ryoji Yoshida Breakdown of academic impact, for papers by P. Hohl
Rankless by CCL
2026